MGHbanner BulfinchBldg
MGH  Neurosurgical Service Home
MGH Neurosurgical Service
Massachusetts General HospitalHarvard Medical School

MGH ShieldHvd Med Sch ShieldPartners Logo
Neurosurgery @ MGHPeople @ MGH NeurosurgeryClinical Centers @ MGH NeurosurgeryResearch @ MGH NSEducation @ MGH NeurosurgerySupport Groups @ MGH NeurosurgeryNews @ MGH NeurosurgeryReferrals @ MGH Neurosurgery
[Divider]

 

Stephen B. Tatter, M.D., Ph.D.

 

MD/PhD Degrees: Cornell University Medical College/
The Rockefeller University
Residency/Fellowship: Massachusetts General Hospital
Harvard Medical School
Neurosurgery
Undergraduate: The University of Michigan
Ann Arbor

Find him at:
http://www.bgsm.edu/bgsm/surg-sci../images/tatter.html

Selected Publications:

Tatter SB, Harsh GR IV. (1997) Current treatment modalities for brain tumors. In Chiocca and Breakefiled, eds. Gene Therapy for Neurologic Diseases Humana, in press

Tatter SB, Butler WE, Chapman PH. (1997) Technical and clinical aspects of proton-beam radiosurgery. In Gildenberg and Tasker, eds. Stereotactic Neurosurgery McGraw-Hill, in press

Tatter SB, Galpern WR, Isacson O (1995). Neurotrophic factor protection against excitotoxic neuronal death. The Neuroscientist , 1:286-297.

Tatter SB, Wilson CB, Harsh GR IV. (1995) Neuroepithelial tumors of the adult brain. In Youmans JR, ed. Neurological Surgery, Fourth Edition, Vol. 4: Tumors. W.B. Saunders Co., Philadelphia, pp. 2612-2684.

Tatter SB, Crowell RM, Ogilvy CS (1995). Aneurysmal and microaneurysmal 'angiogram-negative' subarachnoid hemorrhage. Neurosurgery 37:48-55.

Tatter SB, Crowell RM, Ogilvy CS (1995). Acute lacunar stroke in association with angiogram-negative subarachnoid hemorrhage. Mechanistic implications of two cases. Stroke 26:891-5.

Tatter SB, Galpern WR, Hoogeveen AT, Isacson O (1995). Effects of striatal excitotoxicity on huntingtin-like immunoreactivity. Neuroreport 6:1125-9.

Tatter SB, Edgar MA, Klibanski A, Swearingen B (1995). Symptomatic salivary-rest cyst of the sella turcica (pituitary). Acta Neurochir (Wein), 135:150-3.

Tatter SB, Ogilvy CS (1995). Vascular malformations. General considerations. In Ojemann RG, Ogilvy CS, Crowell RM, Heros RC, eds. Surgical Management of Cerebrovascular Disease, Third edition. Williams & Wilkins, Baltimore, 387-403.

Tatter SB, Ogilvy CS, Golden JA, Ojemann RG, Louis DN (1994). Third ventricular xanthogranulomas clinically and radiologically mimicking colloid cysts. Report of two cases. J Neurosurgery 81:605-9.

Tatter SB, Cosgrove GR, (1994). Hemorrhage into a lumbar synovial cyst causing an acute cauda equina syndrome. Case report. J Neurosurgery 81:449-52.

Barker F, Tatter SB (1994). Flow directed placement of a ventriculo-atrial shunt. Technical report. Neurosurgery 35:534-6.

Tatter SB, Borges LF, Louis DN (1994). Central neurocytomas of the cervical spinal cord. Report of two cases. J Neurosurgery 81:288-93.

Tatter SB, Borges LF, Louis DN (1995). Recurrent central neurocytoma of the spinal cord (letter). J Neurosurgery 82:184.

DiSalvo TG, Tatter SB, O'Gara PT, Neilson GP, DeSanctis RW (1994). Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis. Clin Cardiol 17:340-4.

Ogilvy CS, Tatter SB (1995). Tumors, aneurysms, and vascular malformations during pregnancy. In Schmidek HH, Sweet WH, eds. Operative Neurosurgical Techniques: Indications, Methods and Results, Fourth Edition. W.B. Saunders Co., Philadelphia, in press.

Tatter SB, (1990). Interleukin 6: Mediator of the Acute Phase Reaction, Rockefeller University Ph.D. Dissertation, New York, NY.

Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Sehgal PB, May LT, (1989). Interleukin-6/interferon-beta2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J Immunol 143: 2153-2159.

May LT, Torcia G, Cozzolino F, Ray A, Tatter SB, Santhanam U, Sehgal PB, Stern D, (1989). Interleukin-6 gene expression in human endothelial cells. RNA start sites, multiple IL-6 proteins, and inhibition of proliferation. Biochem Biophys Res Comm 159:991-998.

Ray A, Tatter SB, Santhanam U, Helfgott DC, May LT, Sehgal PB, (1989). Regulation of expression of interleukin-6. Molecular and clinical studies. In PB Sehgal, G Grieninger, and G Tosato, eds. Regulation of the Acute Phase and Immune Responses: Interleukin-6 [Ann N Y Acad Sci 557:] 353-362.

May LT, Santhanam U, Tatter SB, Ghrayeb J, Sehgal PB, (1989). Multiple forms of human interleukin-6. Phosphoglycoproteins secreted by many different tissues. In PB Sehgal, G Grieninger, and G Tosato, eds. Regulation of the Acute Phase and Immune Responses: Interleukin-6 [Ann N Y Acad Sci 557:] 114-119.

Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB, (1989). beta2-Interferon / interleukin-6 in plasma and body fluids during acute bacterial infection. J Immunol 142: 948-953.

Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Sanathanam U, Sherris D, May LT, Sehgal PB, Lowry SF, (1989). Endotoxemia elicits increased circulating beta2-interferon / interleukin-6 in man. J Immunol 142: 2321-2324.

Tatter SB, Santhanam U, Helfgott DC, May LT, Sehgal PB, (1989). Interferon beta2: Clinical Studies. In Y Kawade and S Kobayashi, eds. Biology of the Interferon System, Proceedings of an International Conference, Kyoto, 1988 (International Society for Interferon Research), pp. 375-380.

Ray A, Tatter SB, May LT, Sehgal PB, (1989). Transcriptional activation of the IFN-beta2 promoter by multiple agents. In Y Kawade and S Kobayashi, eds. Biology of the Interferon System, Proceedings of an International Conference, Kyoto, 1988 (International Society for Interferon Research), pp. 39-44.

Tatter SB, Santhanam U, Ray A, Helfgott DC, Ghrayeb J, May LT, Sehgal PB, (1989). Interferon-beta2 / B-cell differentiation factor BSF-2 / hepatocyte stimulating factor. In H Moses, P Lengyel, and C Stiles, eds., Growth Inhibitory and Cytotoxic Polypeptides , (Alan R. Liss, New York), pp.189-202.

Ray A, Tatter SB, May LT, Sehgal PB, (1988). Activation of the human "beta2-interferon / hepatocyte stimulating factor / interleukin-6" promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci (USA) 85: 6701-6705.

May LT, Santhanam U, Tatter SB, Bhardwaj N, Ghrayeb J, Sehgal PB, (1988). Phosphorylation of secreted forms of human beta2-interferon / hepatocyte stimulating factor / interleukin-6. Biochem Biophys Res Comm 152: 1144-1150.

May LT, Ghrayeb J, Santhanam U, Tatter SB, Sthoeger Z, Helfgott DC, Chiorazzi N, Grieninger G, Sehgal PB (1988). Synthesis and secretion of multiple forms of "beta2 interferon / B-cell differentiation factor BSF-2 / hepatocyte stimulating factor" by human fibroblasts and monocytes. J Biol Chem 263: 7760-7766.

Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT (1988). Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the "beta2-interferon/ hepatocyte stimulating factor/ interleukin-6" gene in virus-infected human fibroblasts. J Exp Med 167: 1951-1956.

Santhanam U, Tatter SB, Helfgott DC, Ray A, Ghrayeb J, May LT, Sehgal PB (1988). Structure, genetics, and function of human "beta2-interferon/ B-cell stimulatory factor-2/ hepatocyte stimulating factor" (interleukin-6). In Powanda MC, Oppenheim JJ, Kluger MJ, and Dinarello CA, eds., Monokines and Other Non-lymphocytic Cytokines(Alan R. Liss, New York), pp. 29-34. [Progress in Leukocyte Biology 8: 29-34.]

May LT, Santhanam U, Tatter SB, Ghrayeb J, Sehgal PB (1988). beta2-interferon / B-cell differentiation factor BSF-2 / hepatocyte stimulating factor. A major mediator of the `acute phase response'. In Bonavida B, Gifford GE, Kirchner H, Old LJ, eds, Tumor Necrosis Factor/Cachectin and Related Cytokines, International Conference, Heidelberg, 1987, (S. Karger, Basel), pp. 259-265.

Schatz RA, Wilens TE, Tatter SB, Gregor P, Sellinger OZ (1983). Possible role of increased brain methylation in methionine sulfoximine epileptogenesis. Effects of administration of adenosine and homocysteine thiolactone. J Neurosci Res 10: 437-447.

Porta R, Schatz RA, Tatter SB, Sellinger OZ (1983). The biosynthesis of polyamines in mouse brain. Effects of methionine sulfoximine and adenosylhomocysteine. J Neurochem 40: 836-841.

Schatz RA, Wilens TE, Tatter SB, Sellinger OZ (1982). Hypermethylation in the MSO-epileptogenic brain Reversal by dilantin and phenobarbital. In R.T. Borchardt, E. Usdin, and C. Creveling, eds., The Biochemistry of S-Adenosylmethioine and Related Compounds (Macmillan, London), pp. 675-679.

Porta R, Doyle RL, Tatter SB, Wilens TE, Schatz RA, Sellinger OZ (1981). The biosynthesis of polyamines in the brain of audiogenic seizure-susceptible and -resistant deermice. J Neurochem 37: 723-729.

[Divider]
Disclaimer About Medical Information: The information and reference materials contained herein is intended solely for the information of the reader. It should not be used for treatment purposes, but rather for discussion with the patient's own physician. All visitors to this and associated sites from the Neurosurgical Service at MGH agree to read and abide by the the complete terms of legal agreement found at the Neurosurgery "disclaimer & legal agreement." See also: the MGH Disclaimer, the MGH Privacy Policy, and the MGH Interactive Program Disclaimer - Copyright 2005.
[Divider]
electronswebs
MGH  Neurosurgical Service Home
Research@NeurosurgeryVisitors must read the disclaimer - legal agreement.
All Rights Reserved. Copyright 20005 MGH Neurosurgical Service
Neurosurgery@MGH
IntraNet

(internal access only)
System Info Contact: WebServant or the PageServant or e-mail C.Owen
Last modified: May 11, 2005
Referral@Neurosurgery.MassGeneral.org